share_log

Jupiter Neurosciences Files for Initial Public Offering

Dow Jones Newswires ·  Oct 13, 2021 00:30

By Colin Kellaher

Jupiter Neurosciences Inc. on Tuesday filed with the U.S. Securities and Exchange Commission for an initial public offering.

The filing by the Jupiter, Fla., clinical-stage pharmaceutical company indicates that it plans to raise up to $23 million through the sale of common stock and warrants, although that figure is often used as a placeholder to calculate filing fees.

Jupiter, which has developed a resveratrol platform product targeting treatment of neuro-inflammation, said it will apply to list its shares on the Nasdaq Capital Market under the symbol JUNS.

Write to Colin Kellaher at colin.kellaher@wsj.com

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment